1 / 8

Globalization, intellectual property rights and access to medicines

Globalization, intellectual property rights and access to medicines . Access. Why is “access to medicine” an issue ? Access to medicine: the data The access framework (WHO). Price. Why is price a problem? The demand curve price differences between alternative drugs

anakin
Download Presentation

Globalization, intellectual property rights and access to medicines

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Globalization, intellectual property rights and access to medicines

  2. Access • Why is “access to medicine” an issue? • Access to medicine: the data • The access framework (WHO)

  3. Price • Why is price a problem? • The demand curve • price differences between alternative drugs • International price differences • In low income countries, drugs are largest household and second largest public expenditure for health: the data

  4. Costs • Drug spending in health budgets • Economic burden of drugs • Increasing global drug costs • Drugs share in total health spendingvariations • Drug share in total health spendinginverse relationship with income

  5. Financing • Mechanisms for financing drugsmust be linked to health financing • Mechanisms for financing drugsmust be linked to health financing • General policy prescriptions for meeting future challenges for drug financing • Differential pricing • What works in bringing down price

  6. International agreements affecting price of drugs • WTO agreements relevant for pharmaceutical sector • What are IPRs? • Agreement on Trade-Related Aspects of Intellectual Property Rights • Patents and why are patents seen as problems from ‘public health’ advocates • Access to medicines: which articles of the TRIPS agreement are relevant? • TRIPS aims • Issues on paying for R&D

  7. Doha Declaration • Domestic legislation & policies • Opposition/lobbying by the pharmaceutical industry • Pressure by developed countries to enact TRIPS-plus legislation

More Related